Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapy.

Autor: van der Doelen, Maarten J.1,2 (AUTHOR) Maarten.vanderDoelen@radboudumc.nl, Mehra, Niven1 (AUTHOR), van Oort, Inge M.2 (AUTHOR), Looijen-Salamon, Monika G.3 (AUTHOR), Janssen, Marcel J.R.4 (AUTHOR), Custers, José A.E.5 (AUTHOR), Slootbeek, Peter H.J.1 (AUTHOR), Kroeze, Leonie I.3 (AUTHOR), Bruchertseifer, Frank6 (AUTHOR), Morgenstern, Alfred6 (AUTHOR), Haberkorn, Uwe7 (AUTHOR), Kratochwil, Clemens7 (AUTHOR), Nagarajah, James4,8 (AUTHOR), Gerritsen, Winald R.1 (AUTHOR)
Zdroj: Urologic Oncology. Oct2021, Vol. 39 Issue 10, p729.e7-729.e16. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: